UnitedHealth Group Incorporated (NYSE:UNH) Position Raised by Deprince Race & Zollo Inc.

Deprince Race & Zollo Inc. grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 6.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 81,222 shares of the healthcare conglomerate’s stock after purchasing an additional 4,817 shares during the period. Deprince Race & Zollo Inc.’s holdings in UnitedHealth Group were worth $41,087,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in UNH. Diligent Investors LLC grew its position in UnitedHealth Group by 93.6% in the 4th quarter. Diligent Investors LLC now owns 1,036 shares of the healthcare conglomerate’s stock valued at $524,000 after buying an additional 501 shares in the last quarter. Dunhill Financial LLC increased its stake in shares of UnitedHealth Group by 46.4% during the fourth quarter. Dunhill Financial LLC now owns 612 shares of the healthcare conglomerate’s stock valued at $310,000 after acquiring an additional 194 shares during the period. Eagle Global Advisors LLC boosted its stake in UnitedHealth Group by 3.5% during the 4th quarter. Eagle Global Advisors LLC now owns 37,203 shares of the healthcare conglomerate’s stock valued at $18,820,000 after purchasing an additional 1,245 shares in the last quarter. EHP Funds Inc. raised its stake in shares of UnitedHealth Group by 77.8% in the 4th quarter. EHP Funds Inc. now owns 1,600 shares of the healthcare conglomerate’s stock worth $809,000 after buying an additional 700 shares in the last quarter. Finally, Colonial Trust Co SC raised its position in UnitedHealth Group by 0.6% in the fourth quarter. Colonial Trust Co SC now owns 16,326 shares of the healthcare conglomerate’s stock worth $8,258,000 after acquiring an additional 100 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

NYSE UNH opened at $391.05 on Thursday. The stock has a 50-day simple moving average of $491.52 and a 200 day simple moving average of $525.18. The stock has a market capitalization of $355.95 billion, a PE ratio of 25.23, a P/E/G ratio of 1.37 and a beta of 0.56. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a twelve month low of $385.70 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the prior year, the firm earned $6.91 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 2.15%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 35.18%.

Analyst Ratings Changes

Several research firms recently commented on UNH. KeyCorp cut their target price on shares of UnitedHealth Group from $650.00 to $575.00 and set an “overweight” rating for the company in a research note on Monday, April 21st. Barclays decreased their target price on UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating on the stock in a report on Monday, April 21st. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, JPMorgan Chase & Co. dropped their price target on UnitedHealth Group from $652.00 to $525.00 and set an “overweight” rating on the stock in a research report on Thursday, April 24th. Four research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $596.86.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.